bioAffinity Technologies, Inc. (BIAF) Return on equity 2022–2025
bioAffinity Technologies, Inc. (BIAF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-204.9%FY2025 · since FY2022: -73.8% → -204.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -204.9% | +142.5 pp |
| FY2024 | -347.4% | -183.9 pp |
| FY2023 | -163.5% | -89.6 pp |
| FY2022 | -73.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Net marginBIAF Gross profitBIAF Gross marginBIAF Operating incomeBIAF Operating marginBIAF Operating cash flowBIAF Free cash flowBIAF Capital expendituresBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Total liabilitiesBIAF Shareholders’ equityBIAF overview →